Navigation Links
BodySculpt(TM) Leads FDA Approval of BodyTite(TM) with Largest Number of Documented Study Cases
Date:9/16/2009

NEW YORK, Sept. 16 /PRNewswire/ -- The plastic surgeons at BodySculpt(TM) are revolutionizing the latest techniques in liposuction -- one radio-frequency wave at a time. Since being selected by Invasix to head the FDA approval studies of BodyTite(TM), BodySculpt(TM) has lead the industry in its number of case studies and field research. The latest device in body-contouring procedures, BodyTite(TM) utilizes radio-frequency assisted liposuction (RFAL) technology. With the direction of board certified BodySculpt(TM) Surgical Director Dr. Christopher Chia BodySculpt(TM) is the first team of surgeons in the New York area to use BodyTite(TM) and is the leading authority in RFAL and its introduction to the world of plastic surgery.

BodyTite(TM) is the most compact and ergonomic, energy-assisted liposuction device in the world, in addition to being powerful, minimally invasive and safe. BodyTite(TM) liposuction procedures not only produce successful fat removal with less downtime, but also improve patient safety and comfort.

After conducting several case studies on women with postpartum body insecurities, the plastic surgeons at BodySculpt(TM) have even deemed it as the "virtual no scar tummy-tuck". The RFAL technology induces simultaneous tissue liquefaction, blood vessel coagulation, and heating of the skin, which results in optimal soft tissue contraction and skin tightening. This makes the procedure ideal for postpartum patients or others with compromised skin laxity, such as those who have just experienced extreme weight loss.

Having conducted the largest number of study cases of the procedure in the US, the impressive findings of the doctors at BodySculpt(TM) will aide in determining industry-wide effectiveness and safety standards of BodyTite(TM) once approved by the FDA. Results, reactions, and conclusions thus far have been extremely positive and successful- great news for the FDA approval process, potential patients and surgeons alike.


'/>"/>
SOURCE BodySculpt
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. San Ramon HR Firm Leads Response to New Cal/OSHA ATD Law
2. Genetic Research Leads to New Discovery in Understanding Rare Neurological Disorder
3. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
4. Pharmaleads Lead Candidate for Pain, PL37, Enters Phase I
5. Discovery Leads to Earlier Diagnosis of Type 1 Diabetes
6. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
7. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
8. ISTA Pharmaceuticals Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
9. Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
10. ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis
11. WorldHeart Receives US Clinical Study Approval for the Levacor(TM) VAD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)...  Two Bayer U.S. Pharmaceutical leaders received top awards ... 28 th Woman of the Year ... longstanding mission of furthering the advancement and impact of ... Cindy Powell-Steffen , senior director of brand activation and ... Libby Howe , a regional business manager for New ...
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
(Date:5/10/2017)... Inc. (Nasdaq: HOLX ) announced today the ... April 1, 2017 .   GAAP diluted earnings per ... prior year period as the sale of the blood ... diluted EPS of $0.50 increased 6.4%.  Revenue of $715.4 ... Excluding the effects of blood screening and the acquired ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... May 26, 2017 , ... ... CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface (SDI). Somnoware ... for diagnostic device operations. With this platform, initializing devices and importing studies are ...
(Date:5/26/2017)... Sparks, Nevada (PRWEB) , ... May 26, 2017 ... ... to produce the first ever copper, antimicrobial, mesh back 24/7 task chair specifically ... and conference applications. “We are thrilled to partner with Cupron® to provide ...
(Date:5/26/2017)... Texas (PRWEB) , ... May 26, 2017 , ... Yisrayl ... a new publication this week that is focusing on the Peace Agreements being discussed ... his Middle East sprint in a race to try to speed up peace talks ...
(Date:5/26/2017)... Francisco, CA (PRWEB) , ... May 26, 2017 , ... ... Francisco, is proud to announce a new, informational blog post on insurance options. If ... surgery, checking insurance plans may help save time and money. Visiting an in-network provider ...
(Date:5/26/2017)... ... 26, 2017 , ... Centennial-based BluSky Restoration Contractors announced that ... Annual Clays for Kids fundraiser, to be held Friday, Sept. 22, at Kiowa ... part of BluSky’s partnership with The Adoption Exchange, BluSky will also share sponsorship ...
Breaking Medicine News(10 mins):